US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents
By A Mystery Man Writer
Description
Patent application publication
![US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents](https://images-eureka.patsnap.com/patent_img/96ef755b-f9b8-4e1e-b754-28f9253def5d/US20220064637A1-C00002.png)
Compounds and methods for reducing atxn3 expression - Eureka
![US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents](https://patentimages.storage.googleapis.com/58/8b/ca/2b9e71226ed4a0/US10442756-20191015-C00044.png)
US10442756B2 - Compounds and compositions for intracellular delivery of therapeutic agents - Google Patents
![US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents](https://patentimages.storage.googleapis.com/49/12/61/5b1ad7f8298da4/US20170175113A1-20170622-C00006.png)
US20170175113A1 - Methods for modulating ataxin 2 expression - Google Patents
![US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents](https://patentimages.storage.googleapis.com/13/c7/fc/386dda983031e1/US20220195431A1-20220623-C00018.png)
US20220195431A1 - Compounds and methods for reducing atxn3 expression - Google Patents
![US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents](https://ars.els-cdn.com/content/image/1-s2.0-S0969996119303729-gr10.jpg)
Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein - ScienceDirect
![US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents](https://images-eureka.patsnap.com/patent_img/96ef755b-f9b8-4e1e-b754-28f9253def5d/US20220064637A1-C00003.png)
Compounds and methods for reducing atxn3 expression - Eureka
![US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents](https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41531-022-00278-y/MediaObjects/41531_2022_278_Fig1_HTML.png)
High throughput compound screening in neuronal cells identifies statins as activators of ataxin 3 expression
![US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents](https://patentimages.storage.googleapis.com/6d/b8/1d/ffdddb3069d1f0/imgf000167_0001.png)
WO2020006018A1 - Substituted naphthyridinone compounds useful as t cell activators - Google Patents
![US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents](https://ars.els-cdn.com/content/image/1-s2.0-S0969996119303729-gr8.jpg)
Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein - ScienceDirect
![US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents](https://patentimages.storage.googleapis.com/2d/3b/f4/5fd28a455b00b9/US10808039-20201020-C00025.png)
US10808039B2 - Monomethylvaline compounds capable of conjugation to ligands - Google Patents
![US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents](https://patentimages.storage.googleapis.com/01/f3/3a/3b332754ef0d35/02_image005.png)
TW202113082A - Antisense oligonucleotides targeting atxn3 - Google Patents
![US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents](https://patentimages.storage.googleapis.com/d7/6e/66/07fa30945ee4e1/US20170175113A1-20170622-C00010.png)
US20170175113A1 - Methods for modulating ataxin 2 expression - Google Patents
![US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents](https://patentimages.storage.googleapis.com/f3/f7/73/701c33cadf57c5/US20220195431A1-20220623-C00010.png)
US20220195431A1 - Compounds and methods for reducing atxn3 expression - Google Patents
![US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents](https://patentimages.storage.googleapis.com/ae/c5/99/2c660e6f65e578/US20220195431A1-20220623-C00011.png)
US20220195431A1 - Compounds and methods for reducing atxn3 expression - Google Patents
![US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-023-41192-4/MediaObjects/41598_2023_41192_Fig5_HTML.png)
High throughput compound screening in neuronal cells identifies statins as activators of ataxin 3 expression
from
per adult (price varies by group size)